(Q34734387)

English

The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

author name string

Strahlman ER

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Vogel R

2

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Tipping R

3

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Clineschmidt CM

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

publication date

1 August 1996

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1283-1293

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Separate and combined effects of timolol maleate and acetazolamide in open-angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Carbonic anhydrase inhibitor side effects. Serum chemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of combining timolol with other antiglaucoma medications

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of open-angle glaucoma: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2896%2930509-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0161-6420(96)30509-5

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

release_rvspuc4robhfdkasuzrnjtgvru

1 reference

https://api.fatcat.wiki/v0/release/rvspuc4robhfdkasuzrnjtgvru

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34734387&oldid=1840410712"